Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06762717 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FARAPULSE™ Pulsed Field Ablation System

StatusActive, Not Recruiting
PhaseNot specified
Started2025-10-23
View on ClinicalTrials.gov ↗

Amendment history

2026-09-26
Enrollment closed, study ongoing
2026-08-26
9 amendments v12-v20
9 re-verifications since 2025-12-26, no change to tracked fields
2025-11-23
Study Status v11
Start date2025-10-24→2025-10-23
2025-11-13
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v10
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10-30→confirmed 2025-10-24
2025-09-25
Study Status v9
Start date2025-09-30→2025-10-30
Show 8 earlier versions
2025-08-26
7 amendments v2-v8
7 re-verifications since 2025-02-23, no change to tracked fields
2025-01-23
Study Identification, Study Status v1
Study title-68 characters
An Observational, Prospective, Non-randomized, Single-arm, Multi-center Post-market Study of the FARAPULSE™ Pulsed Field Ablation System
2025-01-06
Original filing
To obtain real world data on the use of, and provide continued evidence on safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) system when used per hospitals' standard of care in Chinese population.
Trial Details
NCT Number NCT06762717
Lead Sponsor Boston Scientific Corporation
Conditions Paroxysmal AF
Enrollment 501 participants
Start Date 2025-10-23
Primary Completion 2027-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-25